Robert Oldham
7PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 10, 2025
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.Javier Cortés, Araceli Priego, Elena Garralda
|Sep 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.Kirstie L S Cleary, Monika Semmrich, Linda Martensson
|Sep 03, 2021
On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation.Joshua M Sopp, Shirley J Peters, Tania F Rowley
|Nov 20, 2020
Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment.Rena Liu, Robert J Oldham, Emma Teal
|Jun 20, 2020
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.Robert J Oldham, C Ian Mockridge, Sonya James
|Feb 18, 2018
The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.Adam Palazzo, Sylvia Herter, Laura Grosmaire
Pageof 2
Frequent Collaborators
5 joint publications
Mark S Cragg
2 joint publications
H T Claude Chan
2 joint publications
Ingrid Teige
2 joint publications
Bjorn Frendeus
2 joint publications
Linda Martensson
2 joint publications
Stephen A Beers
1 joint publications
Patrick Duriez
1 joint publications
Brock F Binkowski
1 joint publications
Philip G Hargreaves
1 joint publications
Adam Palazzo
